Trial Profile
Clinical Trials Insight: 700044745
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 May 2009
Price :
$35
*
At a glance
- Drugs Edotreotide Y-90 (Primary) ; Octreotide
- Indications Carcinoid tumour
- Focus Registrational; Therapeutic Use
- Sponsors Molecular Insight Pharmaceuticals
- 14 May 2009 New trial record.